[Atenolol in treatment of patients with airway obstruction].
It is well known that beta-2-blockers are contraindicated for patients with bronchial hyperactivity. Author discusses the clinical observations in relation to treatment with atenolol in circulatory system pathology.
Chazan
R
R
Katedry i Kliniki Chorób Wewnetrznych i Pneumonologii Akademii Medycznej w Warszawie.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000402:Airway Obstruction / Q000188:drug therapy*; D001262:Atenolol / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000188:drug therapy; D003327:Coronary Disease / Q000188:drug therapy; D006801:Humans; D006973:Hypertension / Q000188:drug therapy
D000319:Adrenergic beta-Antagonists; D001262:Atenolol